Anti-coagulants

Created

2024-03-04

Last Modified

Files

1 Download↓
rx_anticoag.csv (1.07 MB)
↓

Tags






Abstract

Concept set intended to identify patients with an exposure to an anti-coagulant medication.

Affiliation(s)

PEDSnet Data Coordinating Center

Funder(s)

Provenance

This concept set was developed for the Computable Phentotypes for Children with Pulmonary Embolism developed as part of the CENTIPEDE pilot study.

Description

Broad concept set intended to assist in defining a cohort of patients with pulmonary embolism; the presence of a prescription or dispensed anti-coagulant acts as inclusion criteria for the cohort.

Development Code

https://atlassian.chop.edu/bitbucket/projects/PRP/repos/centipede/browse/computational_phenotypes/specs/centipede_aspect_final_codesets.xlsx

Vocabulary

RxNorm , RxNorm Extension

Clinical Subjects Headings

Anticoagulants
Hematologic Agents
Therapeutic Uses

Related Resource

Related Phenotype

Thumbnail Image
Children with Pulmonary Embolism
(10/14/24) PEDSnet Data Coordinating Center
Pediatric pulmonary embolism (PE) research has been limited by rarity at individual centers and a lack of multi-center data sources to investigate treatments and outcomes. The goal of this work was to develop a computable phenotype and utilize it in PEDSnet to compare management strategies and outcomes in a validated cohort of children with PE to improve PE care in children.

Related Person

Related Study

Thumbnail Image
Computable phENotype To Identify Pulmonary Embolism in chilDrEn (CENTIPEDE)
Central Michigan University; Children's Hospital of Philadelphia
Study to test the classification accuracy of an algorithm that has been previously validated in adult pulmonary embolism (PE) patients (“ASPECT”). The algorithm was used to identify a pediatric PE cohort from EHR and evaluate the accuracy of diagnostic and treatment code combinations using EHR data to diagnose pediatric PE at a single center, the Children’s Hospital of Philadelphia.

Related Concept Set

Related Publications

Creative Commons license

a CC-BY Attribution 4.0 License.
Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 License.